You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

RANICLOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Raniclor, and what generic alternatives are available?

Raniclor is a drug marketed by Ranbaxy Labs Ltd and is included in one NDA.

The generic ingredient in RANICLOR is cefaclor. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefaclor profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Raniclor

A generic version of RANICLOR was approved as cefaclor by TEVA on September 4th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for RANICLOR?
  • What are the global sales for RANICLOR?
  • What is Average Wholesale Price for RANICLOR?
Summary for RANICLOR
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 78
Patent Applications: 4,598
DailyMed Link:RANICLOR at DailyMed
Drug patent expirations by year for RANICLOR

US Patents and Regulatory Information for RANICLOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy Labs Ltd RANICLOR cefaclor TABLET, CHEWABLE;ORAL 065092-001 Dec 22, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ranbaxy Labs Ltd RANICLOR cefaclor TABLET, CHEWABLE;ORAL 065092-004 Dec 22, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ranbaxy Labs Ltd RANICLOR cefaclor TABLET, CHEWABLE;ORAL 065092-002 Dec 22, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ranbaxy Labs Ltd RANICLOR cefaclor TABLET, CHEWABLE;ORAL 065092-003 Dec 22, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.